FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200280966> ?p ?o ?g. }

• W4200280966 endingPage "701" @default.
• W4200280966 startingPage "691" @default.
• W4200280966 abstract "This was a retrospective study about sacral giant cell tumor of bone (GCTB).This study aimed to investigate whether ultra-short course of neo-adjuvant denosumab treatment for sacral GCTB could (1) induce radiological and histological response? (2) Facilitate nerve-sparing surgery? (3) Achieve satisfactory oncological and functional outcomes?Previous reports on long course of neo-adjuvant denosumab treatment for GCTB showed significant tumor response and a relatively high recurrent rate after curettage.Sixty-six patients with sacral GCTB treated with neoadjuvant denosumab and nerve-sparing surgery were categorized into ultra-short course group (≤3 doses and operation within D21 since 1st dose, 41 patients) or conventional group (>3 doses or operation after D21 since 1st dose, 25 patients). The radiological and histological response, operative data, oncological and functional outcomes were compared.The ultra-short course group demonstrated fewer doses of neo-adjuvant denosumab (mean: 2.1 vs. 4.8, P < 0.001) and shorter time to surgery (12.2 days vs. 72.3 days, P < 0.001). Similar patterns of radiological and histological response were observed in the two groups with less fibrosis and ossification in the ultra-short course group. The operative duration (199.9 min vs. 187.8 min, P = 0.364) and estimated blood loss (1552.4 mL vs. 1474.0 mL, P = 0.740) were comparable. Most (94.8%) of the patients received adjuvant denosumab. After a mean follow-up of 29.4 months, three cases (8.8%) and five cases (20.8%) showed local recurrence in each group (P = 0.255). The estimated recurrence-free survival (56.2 vs. 51.2 months, P = 0.210) and the functional status [Motor-Urination-Defecation scores: 25.9 vs. 25.7, P = 0.762] did not differ between the two groups.Ultra-short course of neo-adjuvant denosumab for sacral GCTB could elicit radiological and histological responses as conventional course did. The less degree of fibrosis and ossification might facilitate nerve-sparing surgery and help to achieve satisfactory local control and functional status.Level of Evidence: 4." @default.
• W4200280966 created "2021-12-31" @default.
• W4200280966 creator A5009911740 @default.
• W4200280966 creator A5011277638 @default.
• W4200280966 creator A5023206273 @default.
• W4200280966 creator A5023370603 @default.
• W4200280966 creator A5041505370 @default.
• W4200280966 creator A5041786187 @default.
• W4200280966 creator A5045436193 @default.
• W4200280966 creator A5049495932 @default.
• W4200280966 creator A5065900457 @default.
• W4200280966 creator A5072813027 @default.
• W4200280966 creator A5075329229 @default.
• W4200280966 creator A5076833716 @default.
• W4200280966 creator A5080219805 @default.
• W4200280966 creator A5080283046 @default.
• W4200280966 creator A5088678385 @default.
• W4200280966 date "2021-12-27" @default.
• W4200280966 modified "2023-09-26" @default.
• W4200280966 title "Ultra-Short Course of Neo-Adjuvant Denosumab for Nerve-Sparing Surgery for Giant Cell Tumor of Bone in Sacrum" @default.
• W4200280966 cites W1507649428 @default.
• W4200280966 cites W1886239876 @default.
• W4200280966 cites W2046260623 @default.
• W4200280966 cites W2050501144 @default.
• W4200280966 cites W2056340060 @default.
• W4200280966 cites W2076395246 @default.
• W4200280966 cites W2159152276 @default.
• W4200280966 cites W2299351315 @default.
• W4200280966 cites W2316917046 @default.
• W4200280966 cites W2396761562 @default.
• W4200280966 cites W2510111484 @default.
• W4200280966 cites W2548999407 @default.
• W4200280966 cites W2554812284 @default.
• W4200280966 cites W2577993576 @default.
• W4200280966 cites W2587498987 @default.
• W4200280966 cites W2591456828 @default.
• W4200280966 cites W2755386660 @default.
• W4200280966 cites W2787416449 @default.
• W4200280966 cites W2789377758 @default.
• W4200280966 cites W2793466037 @default.
• W4200280966 cites W2810836821 @default.
• W4200280966 cites W2901714472 @default.
• W4200280966 cites W2911776245 @default.
• W4200280966 cites W2969204082 @default.
• W4200280966 cites W2981803080 @default.
• W4200280966 cites W2994556950 @default.
• W4200280966 cites W3004340030 @default.
• W4200280966 cites W3012904880 @default.
• W4200280966 cites W3022716479 @default.
• W4200280966 cites W3090249663 @default.
• W4200280966 cites W3091871172 @default.
• W4200280966 cites W3112395195 @default.
• W4200280966 cites W3121031517 @default.
• W4200280966 cites W4292542148 @default.
• W4200280966 doi "https://doi.org/10.1097/brs.0000000000004318" @default.
• W4200280966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34961753" @default.
• W4200280966 hasPublicationYear "2021" @default.
• W4200280966 type Work @default.
• W4200280966 citedByCount "7" @default.
• W4200280966 countsByYear W42002809662022 @default.
• W4200280966 countsByYear W42002809662023 @default.
• W4200280966 crossrefType "journal-article" @default.
• W4200280966 hasAuthorship W4200280966A5009911740 @default.
• W4200280966 hasAuthorship W4200280966A5011277638 @default.
• W4200280966 hasAuthorship W4200280966A5023206273 @default.
• W4200280966 hasAuthorship W4200280966A5023370603 @default.
• W4200280966 hasAuthorship W4200280966A5041505370 @default.
• W4200280966 hasAuthorship W4200280966A5041786187 @default.
• W4200280966 hasAuthorship W4200280966A5045436193 @default.
• W4200280966 hasAuthorship W4200280966A5049495932 @default.
• W4200280966 hasAuthorship W4200280966A5065900457 @default.
• W4200280966 hasAuthorship W4200280966A5072813027 @default.
• W4200280966 hasAuthorship W4200280966A5075329229 @default.
• W4200280966 hasAuthorship W4200280966A5076833716 @default.
• W4200280966 hasAuthorship W4200280966A5080219805 @default.
• W4200280966 hasAuthorship W4200280966A5080283046 @default.
• W4200280966 hasAuthorship W4200280966A5088678385 @default.
• W4200280966 hasConcept C126322002 @default.
• W4200280966 hasConcept C126894567 @default.
• W4200280966 hasConcept C141071460 @default.
• W4200280966 hasConcept C2776286101 @default.
• W4200280966 hasConcept C2776541429 @default.
• W4200280966 hasConcept C2776886416 @default.
• W4200280966 hasConcept C2777308945 @default.
• W4200280966 hasConcept C2779455797 @default.
• W4200280966 hasConcept C2779904257 @default.
• W4200280966 hasConcept C71924100 @default.
• W4200280966 hasConceptScore W4200280966C126322002 @default.
• W4200280966 hasConceptScore W4200280966C126894567 @default.
• W4200280966 hasConceptScore W4200280966C141071460 @default.
• W4200280966 hasConceptScore W4200280966C2776286101 @default.
• W4200280966 hasConceptScore W4200280966C2776541429 @default.
• W4200280966 hasConceptScore W4200280966C2776886416 @default.
• W4200280966 hasConceptScore W4200280966C2777308945 @default.
• W4200280966 hasConceptScore W4200280966C2779455797 @default.
• W4200280966 hasConceptScore W4200280966C2779904257 @default.
• W4200280966 hasConceptScore W4200280966C71924100 @default.
• W4200280966 hasIssue "9" @default.

• next